symbol,statement_type,period_end,line_item,value
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,1333447000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,-58587000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-1111722000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,End Cash Position,9045000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,151421000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,-142376000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-987680000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,1597000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-6332000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-915392000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Common Stock Dividend Paid,-915392000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,-58587000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,-58587000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,-58587000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-1599865000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,29946000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,-520079000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,8330481000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,-8850560000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-1109732000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,1990000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-1111722000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,2445169000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-1094187000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-1707576000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,216627000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,-139404000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Change In Payable,220891000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-317134000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-1707877000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,-12763000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,-9480000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,543735000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Depreciation,543735000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-222637000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-12924000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,2247000.0
CONCORDBIO.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,4945533000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,1797786000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-250058000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-856885000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,End Cash Position,151421000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,34992000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,116429000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-992149000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,13912000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-26496000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-714529000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Common Stock Dividend Paid,-714529000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,-250058000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,0.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,-250058000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,-250058000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-1546093000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,27728000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,-718687000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,7662313000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-8381000000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-855134000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,1751000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-856885000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,2654671000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-1033496000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-811798000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,61309000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,3329000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Change In Payable,-112866000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,43609000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,-786596000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,-15688000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,6313000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,535915000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,3388000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Depreciation,535915000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-140647000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,22254000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,-119000.0
CONCORDBIO.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,4125650000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,1009170000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,-250000000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,0.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-1450848000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,End Cash Position,34992000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,6669000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,28323000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,-852194000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,32356000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-39582000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-535635000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Common Stock Dividend Paid,-535635000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,-293372000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,-43372000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,-250000000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,-250000000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,0.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-1579501000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,55849000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-184755000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,6246237000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-6430992000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-1450595000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,253000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-1450848000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,2460018000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-702766000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-522855000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,-92053000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,-191310000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Change In Payable,98806000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,-172273000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-430971000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,-21947000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,-16585000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,540324000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,33794000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Depreciation,506530000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,-37169000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,19535000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,940000.0
CONCORDBIO.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,3220134000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,519700000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,-250020000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,0.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-1555050000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,End Cash Position,6670000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,51440000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,-44770000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-1001640000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,30890000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-53150000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-705210000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Common Stock Dividend Paid,
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-257630000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,-7610000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,-250020000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,-250020000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,0.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-1117880000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,41390000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,395220000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,5614360000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,-5219140000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-1554490000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,560000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-1555050000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,2074750000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-607850000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-220530000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,114060000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,241700000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Change In Payable,365320000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-415090000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-527690000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,-22400000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,19240000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,500500000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,33950000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Depreciation,466550000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-52300000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-18350000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,340000.0
CONCORDBIO.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,2375180000.0
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,519720000.0
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Common Stock Dividend Paid,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,50990000.0
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,519720000.0
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,32580000.0
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Depreciation,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
CONCORDBIO.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
